Screener
IBRN vs IDNA
iShares Neuroscience and Healthcare ETF vs iShares Genomics Immunology and Healthcare ETF
Key differences
- IDNA is significantly larger than IBRN — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, IBRN has delivered higher annualized returns.
Side-by-side comparison
| IBRN | IDNA | |
|---|---|---|
| Annual cost (TER) | 0.47% | 0.47% |
| Fund size (AUM) | $5M | $160M |
| Since | 2022 | 2019 |
| Dividend yield | 0.93% | 1.05% |
| Asset class | equity | equity |
| Region | — | — |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +56.8% | +49.2% |
| CAGR 3Y | +10.6% | +8.0% |
| CAGR 5Y | N/A | -7.5% |
| Sharpe 3Y | 0.39 | 0.29 |
| Volatility 1Y | 25.00% | 24.43% |
| Max drawdown | -35.39% | -68.26% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to IBRN and IDNA
Explore further